Chemistry:ABT-202
From HandWiki
Short description: Chemical compound
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C9H13N3 |
Molar mass | 163.219 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
ABT-202 is a drug developed by Abbott, which acts as an agonist at neural nicotinic acetylcholine receptors and has been researched for use as an analgesic, although it has not passed clinical trials.[1][2][3]
References
- ↑ "Modulators of nicotinic acetylcholine receptors as analgesics". Current Opinion in Investigational Drugs 5 (1): 76–81. January 2004. PMID 14983978.
- ↑ "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem 2 (6): 746–67. June 2007. doi:10.1002/cmdc.200600207. PMID 17295372.
- ↑ "Automated 96-well liquid-liquid back extraction liquid chromatography-tandem mass spectrometry method for the determination of ABT-202 in human plasma". Journal of Pharmaceutical and Biomedical Analysis 36 (1): 189–95. September 2004. doi:10.1016/j.jpba.2004.05.013. PMID 15351065.
nAChRs |
| ||||
---|---|---|---|---|---|
Precursors (and prodrugs) | |||||
0.00 (0 votes)
|